Cargando…
Establishment of a mouse model of cancer cachexia with spleen deficiency syndrome and the effects of atractylenolide I
Cancer cachexia is a multifactorial metabolic syndrome that affects ∼50%–80% of cancer patients, and no effective therapy for cancer cachexia is presently available. In traditional Chinese medicine, a large portion of patients with cancer cachexia was diagnosed as spleen deficiency syndrome and trea...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Singapore
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470874/ https://www.ncbi.nlm.nih.gov/pubmed/31341256 http://dx.doi.org/10.1038/s41401-019-0275-z |